Emma Louise Klatman
Emma Louise Klatman publishes mostly in Endocrinology, Diabetes and Metabolism, Genetics and General Health Professions, on topics such as Diabetes Management and Research, Diabetes and associated disorders and Diabetes Management and Education.
- World rank
- #2,629,908 of 7,710,434 ranked researchers
- Rank in Australia
- #73,248 of 140,210
- Works
- 18
- Citations
- 890
- Citations per work
- 49.4
What does Emma Louise Klatman research?
Emma Louise Klatman's work is mostly in Medicine (43%), Biochemistry, Genetics and Molecular Biology (15%), Health Professions (13%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1056.6%
- Medicine843.4%
- Health Professions213.2%
- Everything else316.9%
- Life Sciences315.1%
- Social Sciences211.4%
- 1Endocrinology, Diabetes and Metabolism43% of their works
- 2Genetics15% of their works
- 3General Health Professions9% of their works
- 4Organizational Behavior and Human Resource Management6% of their works
- 5Economics and Econometrics6% of their works
- 6Speech and Hearing4% of their works
Research topics
- Diabetes Management and Research
- Diabetes and associated disorders
- Diabetes Management and Education
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Global Public Health Policies and Epidemiology
- Health Systems, Economic Evaluations, Quality of Life
- Adolescent and Pediatric Healthcare
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
Which keywords describe Emma Louise Klatman's research?
The keywords of their largest research topics: Diabetes, Glycemic Control, Type 1 Diabetes, Cardiovascular Disease, Insulin Therapy, Continuous Glucose Monitoring, Hypoglycemia and Autoimmunity.
- Transition
- Critical Care
- Quality of Life
- Metabolic Syndrome
- Cost-effectiveness Analysis
- Depression
- Self-Management
- Autoimmunity
- Continuous Glucose Monitoring
- Cardiovascular Disease
- Glycemic Control
- Diabetes
- Type 1 Diabetes
- Insulin Therapy
- Hypoglycemia
- Genetics
- Chronic Disease
- Corporate Political Activity
- Insulin Resistance
- Non-Communicable Diseases
- Adolescents
- Hyperglycemia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Diabetes213 topics
- Glycemic Control203 topics
- Type 1 Diabetes202 topics
- Cardiovascular Disease152 topics
- Insulin Therapy142 topics
- Continuous Glucose Monitoring121 topic
- Hypoglycemia121 topic
- Autoimmunity81 topic
- Genetics81 topic
- Self-Management82 topics
- Chronic Disease61 topic
- Depression61 topic
- Corporate Political Activity31 topic
- Cost-effectiveness Analysis31 topic
- Insulin Resistance31 topic
- Metabolic Syndrome31 topic
- Non-Communicable Diseases31 topic
- Quality of Life31 topic
- Adolescents21 topic
- Critical Care21 topic
- Hyperglycemia21 topic
- Transition21 topic
Where does Emma Louise Klatman work?
Emma Louise Klatman's main affiliation in the publication record is Diabetes Australia, Australia.
How many publications and citations does Emma Louise Klatman have?
OpenAlex counts 18 works and 890 citations for Emma Louise Klatman, an h-index of 10, ranking #2,629,908 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Emma Louise Klatman. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.